Yongin, South Korea

Hyun-Kyung Yu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mogam Biotechnology Institute. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyun-Kyung Yu. Retrieved from https://idiyas.com/inventor/hyun-kyung-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Hyun-Kyung Yu

Introduction

Hyun-Kyung Yu is a notable inventor based in Yongin-si, South Korea. She has made significant strides in the field of biotechnology, particularly in cancer research. Her work focuses on developing effective treatments that can reduce tumor growth.

Latest Patents

Hyun-Kyung Yu holds a patent for an anticancer agent. The patent discloses a method of reducing tumor growth by contacting the tumor with a tumor growth reducing effective amount of a composition comprising LK8 or LK68 protein or a functionally equivalent amino acid variant thereof, along with a pharmaceutically acceptable carrier. This innovative approach offers new hope for patients battling tumors.

Career Highlights

Yu is affiliated with the Mogam Biotechnology Institute, where she conducts her research and development. Her contributions to the field have been recognized for their potential impact on cancer treatment and patient care.

Collaborations

She has collaborated with notable colleagues, including Jang-Seong Kim and Jin-Hyung Ahn, to advance her research initiatives. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Hyun-Kyung Yu's work exemplifies the spirit of innovation in biotechnology. Her dedication to developing effective cancer treatments is paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…